Christopher Gardner, PhD: CTC Director. Dr. Gardner, Professor of Medicine, Stanford Prevention Research Center, has extensive experience in successful study design, recruitment and retention. He also directs a NIH/NHLBI T32 fellow training program, and has advised national organizations, including the AHA Nutrition Scientific Advisory committee and the Obesity Society Education Committee. He will direct the CTC and the CTC Clinical Trials Support hub.
Tracey McLaughlin, MD: CTC Associate Director. Dr. McLaughlin is Professor in the Department of Medicine, Division of Endocrinology. She splits her time between caring for patients with diabetes and clinical and translational research on diabetes, insulin resistance, obesity, and metabolism. She has led multiple NIH, ADA, AHA and industry-sponsored clinical trials and is well versed in the procedures necessary to set up trials with IRB and the Clinical-Translational Research Unit. Dr. McLaughlin will oversee the CTC Biorepository core and assist with clinical recruitment/consenting for the clinical registry and coordinating biobank sample collection and management to improve research efficiency and facilitate collaborations between DRC investigators.
Manisha Desai, PhD: CTC Associate Director. Dr. Desai is Professor of Medicine and of Biomedical Data Science. She is the founder and director of the Stanford Quantitative Sciences Unit (QSU), a biostatistical unit of over 20 faculty, PhD-, and Masters-level staff started in 2009. The QSU provides the statistical infrastructure for large-scale research projects at the School of Medicine. As Associate-Director of the CTC, Dr. Desai will oversee the CTC Analytic Support team.